AU1916601A - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer

Info

Publication number
AU1916601A
AU1916601A AU19166/01A AU1916601A AU1916601A AU 1916601 A AU1916601 A AU 1916601A AU 19166/01 A AU19166/01 A AU 19166/01A AU 1916601 A AU1916601 A AU 1916601A AU 1916601 A AU1916601 A AU 1916601A
Authority
AU
Australia
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19166/01A
Other languages
English (en)
Inventor
Douglas Wade Beight
William Thomas Mcmillen
Jason Scott Sawyer
Edward C. R. Smith
Beverly Ann Teicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1916601A publication Critical patent/AU1916601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19166/01A 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer Abandoned AU1916601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16490099P 1999-11-11 1999-11-11
US60164900 1999-11-11
PCT/US2000/030941 WO2001034198A2 (fr) 1999-11-11 2000-11-09 Combinaisons oncolytiques pour traitement des cancers

Publications (1)

Publication Number Publication Date
AU1916601A true AU1916601A (en) 2001-06-06

Family

ID=22596581

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19166/01A Abandoned AU1916601A (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU1916601A (fr)
WO (1) WO2001034198A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
EP1326605A4 (fr) * 2000-05-09 2004-03-17 Univ Creighton Procedes servant a inhiber la proliferation et a induire l'apoptose dans des cellules cancereuses
AU2001282717A1 (en) 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
DE10359828A1 (de) * 2003-12-12 2005-07-28 Zoser B. Dr.Rer.Nat. Salama CHP-Gemcitabin- Kombinationsmittel und ihre Verwendung als Antitumorwirkstoffe, insbesondere Antimetastasierungswirkstoffe
WO2008044729A1 (fr) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Dérivé d'acide carboxylique
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
CA2857521C (fr) 2012-01-10 2016-03-01 Eli Lilly And Company Compose antagoniste des leucotrienes b4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1595101A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001034133A2 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Combinaisons oncolytiques pour traitement des cancers
TR200201245T2 (tr) * 1999-11-11 2004-08-23 Eli Lilly And Company Kanser tedavisi için onkolitik kombinasyonlar.
WO2001034197A2 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Combinaisons oncolytiques aux fins du traitement de cancer
CA2390789A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Combinaisons oncolytiques pour traitement des cancers

Also Published As

Publication number Publication date
WO2001034198A2 (fr) 2001-05-17
WO2001034198A3 (fr) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2020501A (en) Chemotherapy treatment
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU3791601A (en) Treatment of coal
EP1176964B8 (fr) Utilisation du compose et743 pour le traitement du cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
AU5089400A (en) Arthritis treatment
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU5547000A (en) Novel treatment
AU7363000A (en) Method for reducing the risk of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU4556800A (en) Novel treatment
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU2001257325A1 (en) Cancer treatment
AU1592901A (en) Oncolytic combinations for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase